文献速递慢病管理预防保健、筛查与疫苗老年与多病共存

维生素D在常见病与高死亡率疾病中的循证综述

An Evidence-Based Review of Vitamin D for Common and High-Mortality Conditions.
PubMed 文献 · J Am Board Fam Med · 2022-11-17

本文综述随机对照试验、荟萃分析、系统综述及大型前瞻性试验,评估维生素D在基层常见病及2010年以来十大死因相关疾病中的预防与治疗作用。结果显示补充维生素D对心血管病、高血压、癌症预防及认知改善无明显效果,但可能降低COVID-19严重程度与机械通气风险、减少跌倒风险(中等剂量)、改善抑郁与纤维肌痛疼痛、延缓糖尿病前期进展并辅助改善特应性皮炎。

要点

  • 已知心血管病患者补充维生素D不降低卒中或心梗风险
  • 中等剂量可能减少跌倒风险,高剂量反而可能增加跌倒风险
  • 糖尿病前期补充维生素D可降低进展为2型糖尿病的风险

核心结论

  • 前瞻性补充维生素D研究显示其对疾病特异性和患者导向结局影响不一,提示低维生素D水平与疾病之间为相关性而非因果性。
  • 未来研究应确定维生素D用于治疗和预防的剂量标准与时机。

研究设计与样本

  • 本文为文献综述,检索随机对照试验、荟萃分析、系统综述及大型前瞻性试验,聚焦基层常见病及2010年以来十大死因相关疾病。

主要发现

  • 已知心血管疾病患者补充维生素D不降低卒中或心脏病发作风险。
  • 补充维生素D对高血压治疗或癌症预防似乎无效。
  • 新兴证据显示补充维生素D可降低COVID-19严重程度和机械通气风险。
  • 中等水平维生素D可能降低跌倒风险,但较高剂量可能增加跌倒风险。
  • 补充维生素D与认知改善似乎无关联。

临床怎么用

  • 对已知心血管疾病患者不应期待补充维生素D降低卒中或心梗风险。
  • 对糖尿病前期患者可考虑补充维生素D以降低进展为2型糖尿病的风险。
  • 使用维生素D预防跌倒时应避免高剂量,因高剂量可能增加跌倒风险。

局限性

  • 低维生素D水平与疾病的关联多来自观察性研究,补充试验结果不一,提示相关性而非因果性。
  • 未来需进一步研究确定维生素D的剂量标准与使用时机。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vitamin D is a fat-soluble vitamin available from food and sun exposure. Vitamin D receptors are present in cells throughout the body and cause it to act like a hormone. Observational studies document the association of low vitamin D levels with multiple health conditions. This article reviews the evidence for vitamin D in prevention and treatment in primary care. METHODS: We performed a literature review of randomized controlled trials, meta-analyses, systematic reviews, and large prospective trials looking at the role of vitamin D deficiency in the most common conditions seen in primary care and the top 10 causes of mortality since 2010. RESULTS: Vitamin D supplementation in patients with known cardiovascular disease does not reduce risk of stroke or heart attack. Vitamin D supplementation does not seem to have an effect in the treatment of hypertension or in cancer prevention. There is emerging evidence that supplementation reduces COVID-19 severity and risk of mechanical ventilation. Vitamin D at more moderate levels may reduce the risk of falls, but higher doses may cause increased fall risk. There does not seem to be a link between vitamin D supplementation and improved cognition. Vitamin D supplementation may be helpful in patients with major depression. High dose vitamin D may improve pain in people with fibromyalgia. Supplementing patients with prediabetes reduced the risk of progression to type 2 diabetes mellitus. Vitamin D supplementation in addition to standard emollient treatment helped to reduce symptoms in people with atopic dermatitis. CONCLUSION: Prospective studies of vitamin D supplementation demonstrate variable impact on disease specific and patient-oriented outcomes, suggesting a correlation but not a causal relationship between low vitamin D levels and disease pathogenicity. Future research should determine dosing standards and timing of vitamin D in treatment and prevention.

来源:J Am Board Fam Med,查看原文。版权归原作者所有。

引用

  1. Michael W, Couture AD, Swedlund M, et al. An Evidence-Based Review of Vitamin D for Common and High-Mortality Conditions. J Am Board Fam Med. 2022. PMID: 36396409. doi:10.3122/jabfm.2022.220115R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。